Predictive BioSciences
Company Team Investors Careers Media Contact
  • Press
    Releases
  • News
  • Events
  • Posters/
    Abstracts
  • Publications
  • 3.4.10

  • Predictive Biosciences to Present Novel Combination Approach to Molecular Cancer Diagnostics at 2010 Genitourinary Cancers Symposium
  • 2.2.10

  • Diagnostic Industry Veteran Kim Blickenstaff Joins Predictive Biosciences’ Board of Directors
  • 1.7.10

  • Predictive Biosciences Announces Acquisition of OncoDiagnostic Laboratory
  • 12.11.09

  • Predictive Biosciences Licenses DNA Biomarker FGFR3 for Bladder Cancer Diagnostic Use
  • 12.2.09

  • Predictive Biosciences Presents Novel Multi-Analyte Approach to Diagnostic Assay Development at Annual Meeting of the Society of Urologic Oncology (SUO)
  • 11.3.09

  • Predictive Biosciences Announces Publication in Journal of Urology of Results from a Pilot Study of its Non-Invasive Assay to Monitor Patients for Bladder Cancer
  • 3.5.09

  • Predictive Biosciences’ Breast Cancer Biomarker Findings Highlighted in Proceedings of the National Academy of Sciences
  • 10.22.08

  • Predictive Biosciences to Present at First Annual Boston Biotech R&D Conference
  • 10.16.08

  • Predictive Biosciences Closes $21.75 Million in Series B Financing
  • 7.16.08

    Predictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran Appointments

  • 6.10.08

    Predictive Biosciences to Participate in Panel Discussion at the
    BIO 2008 International Convention
  • 3.19.08

    Predictive Biosciences Appoints Life Sciences Industry Veteran Peter Klemm, Ph.D., as Company's First President and CEO
  • 1.31.08

    Predictive Biosciences appoints Martin Madaus, Millipore CEO and Chairman, to Board of Directors
  • 7.18.07

    Predictive Biosciences Announces Pilot Study Results at GTCBio’s “Rediscovering Biomarkers” Conference
  • 5.30.07

    Predictive Biosciences Forms Scientific Advisory Board
  • 12.18.06

    Predictive Biosciences Raises $10 Million in Funding to Revolutionize Cancer Management Using Novel Biomarkers
Company | Team | Investors | Careers | Media | Contact    ©2006-2008 Predictive Biosciences, Inc.